GoodRx Holdings Inc (GDRX) reports robust growth in adjusted EBITDA and Pharma Manufacturer Solutions revenue, despite facing ...

Over the past few days, the news from GoodRx Holdings (NASDAQ: GDRX) hasn't been all that good. On Thursday the online ...

GoodRx (NASDAQ: GDRX) Q3 2024 Earnings Call Nov 07, 2024, 8:00 a.m. ET ...

GoodRx (NASDAQ:GDRX – Get Free Report) had its price target lowered by Barclays from $10.00 to $6.00 in a research note ...

Barclays lowered the firm’s price target on GoodRx (GDRX) to $6 from $10 and keeps an Overweight rating on the shares post the Q3 report.

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX – Research Report), ...

Harrow (HROW) stock plunged 20% post-market after the eye care drugmaker’s Q3 earnings report missed Street estimates on the ...

On Monday, Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.89 which represents no change from the prior close of of $4.89. The stock opened at $4.98 and touched a low of $4.

GoodRx has been hit with a series of antitrust class actions in California and Rhode Island federal courts challenging the ...

Raymond James has recently raised Goodrx Holdings Inc (GDRX) stock to Strong Buy rating, as announced on August 9, 2024, according to Finviz. Earlier, on May 23, 2024, RBC Capital Mkts had raised the ...

Struggling with high prescription costs? GoodRx is helping millions save up to 80% on their medications through price ...

Whether you have Medicare, Marketplace insurance or employer-provided, don't auto select your coverage this year.